Researchers studying gene expression have access to vast amounts of data from cells or tissues. This is thanks to advances in ...
Researchers found that maternal morbidity risks were higher among women who underwent in vitro fertilization or intrauterine ...
Researchers uncover key mechanisms in gene regulation that may lead to better design of RNA-based medicines.
RNA-based medicines are one of the most promising ways to fight human disease, as demonstrated by the recent successes of RNA ...
WVE-007 is a novel, long-acting GalNAc-siRNA targeting INHBE mRNA – a genetically validated target that provides a new ...
RNA-based medicines are one of the most promising ways to fight human disease, as demonstrated by the recent successes of RNA vaccines and double-stranded RNA (dsRNA) therapies. But while health care ...
RNA-based medicines are one of the most promising ways to fight human disease, as demonstrated by the recent successes of RNA ...
A study reveals DNA and RNA epigenetics work together as a complementary system for precise gene regulation, crucial for cell ...
TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that Cohort 3 of its Phase 1 clinical trial ...
Postdoctoral scholar Daniela Soto has earned a prestigious fellowship from HHMI with eight years of funding to study the ...
1h
News Medical on MSNRUFY1-RET fusion identified as mechanism of resistance to lorlatinib in lung cancerA new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled "Acquired RUFY1-RET rearrangement as a mechanism of resistance to lorlatinib in a patient with CD74-ROS1 ...
Wave Life Sciences (WVE) announced clinical trial application, CTA, approval and initiation of the Phase 1 INLIGHT clinical trial of WVE-007 in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results